Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» epacadostat
epacadostat
Incyte wipes out late-phase epacadostat program after pivotal failure of Keytruda combination
Fierce Biotech
Wed, 05/2/18 - 09:55 am
Incyte
epacadostat
Keytruda
IDO inhibitors
[video]Why One Drug Flop Tanked Incyte's Stock
Motley Fool
Thu, 04/12/18 - 10:58 pm
Incyte
epacadostat
Incyte's Horrible News Derails a Promising Class of Cancer Drugs
Motley Fool
Fri, 04/6/18 - 07:43 pm
Incyte
Merck
epacadostat
IDO inhibitors
Roche
NewLink Genetics
Incyte's stock plunges, Merck shares fall after disappointing study results of melanoma treatment
Marketwatch
Fri, 04/6/18 - 09:51 am
Incyte
Merck
melanoma
epacadostat
Keytruda
clinical trials
metastatic melanoma
5 Biggest New Drugs of 2018
Motley Fool
Sun, 01/7/18 - 12:35 pm
Gilead Sciences
Bictegravir/F/TAF
Novo Nordisk
semaglutide
Ozempic
Incyte
epacadostat
AbbVie
Rova-T
Celgene
ozanimod
3 Promising Cancer Immunotherapies to Watch in 2018
Yahoo/Motley Fool
Fri, 12/22/17 - 09:46 am
cancer
immuno-oncology
Incyte
epacadostat
Bristol-Myers Squibb
relatlimab
Nektar
NKTR-214
The top 10 prospective blockbuster drug launches slated for 2018 — Evaluate
Endpoints
Sun, 12/17/17 - 11:47 am
drug launches
Bictegravir/F/TAF
Gilead Sciences
semaglutide
Novo Nordisk
epacadostat
Incyte
Rova-T
AbbVie
ozanimod
Celgene
apalutamide
JNJ
Elagolix
AVXS-101
AveXis
lanadelumab
Shire
Epidiolex
GW Pharma
AstraZeneca plans new pivotal lung cancer trial with Incyte
Yahoo/Reuters
Tue, 10/31/17 - 10:04 am
AstraZeneca
Incyte
clinical trials
Imfinzi
epacadostat
lung cancer
Incyte’s good week continues with an encouraging update on IDO1 star epacadostat
Endpoints
Thu, 08/31/17 - 10:07 pm
Incyte
IDO1
epacadostat
Keytruda
Merck
3 Most Promising Cancer Drugs in Late-Stage Development
Motley Fool
Tue, 08/22/17 - 10:04 am
Eli Lilly
abemaciclib
advanced breast cancer
Incyte
epacadostat
Imbruvica
JNJ
prostate cancer
Incyte keeps the ASCO spotlight focused on its closely-watched IDO1 drug epacadostat
Endpoints
Mon, 06/5/17 - 10:08 am
Incyte
ASCO 2017
epacadostat
non-small cell lung cancer
Keytruda
Incyte gets a boost from a series of positive data snapshots for its epacadostat/Keytruda combo
Endpoints
Thu, 05/18/17 - 12:08 am
Incyte
epacadostat
ASCO 2017
Merck
Keytruda
non-small cell lung cancer
Does Incyte Have The Best Cancer Portfolio Among Mid-Cap Biotechs?
Barron's
Tue, 04/11/17 - 10:07 am
Incyte
epacadostat
olumiant
Jakafi
immuno-oncology
Merck, Incyte Expand Cancer Collaboration
Barron's
Fri, 03/31/17 - 10:00 pm
Merck
Incyte
epacadostat
Keytruda
melanoma
Updated Incyte combo data for epacadostat/Keytruda look promising
Endpoints
Fri, 10/7/16 - 09:09 am
Incyte
epacadostat
Keytruda
Merck, Incyte eye a winning cancer combo with widened collaboration
Fierce Biotech
Tue, 10/13/15 - 09:57 am
Merck
Incyte
cancer
Keytruda
epacadostat
Incyte Hits High On Cancer Drug Data, Buyout Talk
Investors.com
Fri, 09/11/15 - 05:56 pm
Incyte
M&A
epacadostat
Yervoy
melanoma
Bristol-Myers Squibb